EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Cognitive Footprint of Medication Use

Marta Suárez Pinilla, Charlotte R Stoner, Martin Knapp, Parashkev Nachev, Martin Rossor iD

Brain and Behavior · 2025

DOI: 10.1002/brb3.70200 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain and Behavior, 2025. Verfasst von Marta Suárez Pinilla und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Neuroscience Laboratory, Center for Biomedical Technology, Universidad Politécnica de Madrid, Madrid, Spain. Hauptthemen laut MEDLINE: Cognition, Drug-Related Side Effects and Adverse Reactions, Cognition Disorders. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Health Foundation, National Institute for Health and Care Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The cognitive side‐effects of medication are common, but often overlooked in practice, and not routinely considered in interventional trials or post‐market surveillance. The cognitive footprint of a medication seeks to quantify the impact of its cognitive effects based on magnitude, duration, and interaction with other factors, evaluated across the exposed population.

Methods

Bayesian multivariable regression analysis of retrospective population‐based cross‐sectional cohorts.

Results

We replicate positive and negative cognitive effects of commonly used medications in UK Biobank, and extend observed associations to two additional cohorts, the EPIC Norfolk, and the Caerphilly Prospective Cohort. We quantify the resultant cumulative impact at the population level given known patterns of prescribing and compare it with exemplar common diseases.

Conclusion

The cognitive side‐effects of commonly used drugs may have significant impact at the population level. Consideration should be given to a routine structured assessment of cognition in interventional trials and post‐market surveillance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CognitionDrug-Related Side Effects and Adverse ReactionsCognition DisordersHumansRetrospective StudiesMaleFemaleCross-Sectional StudiesBayes TheoremMiddle AgedAgedUnited Kingdom

Stichwörter der Autor:innen

medications | cognitive footprint | large‐scale cohorts | medication side effec…

Autor:innen und Institutionen

  • Clinical Neuroscience Laboratory, Center for Biomedical Technology, Universidad Politécnica de Madrid, Madrid, Spain.
  • UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Centre for Chronic Illness and Ageing, School of Human Sciences, University of Greenwich, Park Row, London.
  • Health Policy Department, London School of Economics and Political Science, London, UK.

ORCID-Profile: Martin Rossor

Förderung

  • Wellcome Trust
  • Health Foundation
  • National Institute for Health and Care Research

Zitieren

APA

Pinilla, M. S., Stoner, C. R., Knapp, M., Nachev, P., & Rossor, M. (2025). The Cognitive Footprint of Medication Use. Brain and Behavior. https://doi.org/10.1002/brb3.70200

Vancouver

Pinilla MS, Stoner CR, Knapp M, Nachev P, Rossor M. The Cognitive Footprint of Medication Use. Brain and Behavior. 2025. doi:10.1002/brb3.70200

BibTeX
@article{Pinilla2025,
  author = {Pinilla, Marta Suárez and Stoner, Charlotte R and Knapp, Martin and Nachev, Parashkev and Rossor, Martin},
  title = {The Cognitive Footprint of Medication Use},
  journal = {Brain and Behavior},
  year = {2025},
  doi = {10.1002/brb3.70200}
}
Kostenlos starten →